| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/09/2006 | CN1816355A Tablet and process for producing the same |
| 08/09/2006 | CN1816354A Enhancement of development of oviparous species by in ovo feeding of enteric modulators |
| 08/09/2006 | CN1816352A Methods for treating cancer using an immunotoxin |
| 08/09/2006 | CN1816347A Human serum albumin-free stabilised interferon liquid formulations |
| 08/09/2006 | CN1816345A Preventive and/or remedy for diseases accompanied by tissue destruction |
| 08/09/2006 | CN1816325A Hydrophilic adhesives for delivery of herbal medicines |
| 08/09/2006 | CN1814778A Method for preparing medical collagen protein powder |
| 08/09/2006 | CN1814301A Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 08/09/2006 | CN1814300A Glinide drug adjuvant composition and method for preparing drug containing same |
| 08/09/2006 | CN1814299A Macrolide antibiotics sodium hyaluronate eye transfer system |
| 08/09/2006 | CN1814298A Transdermal formulation hydrogel substrate and its preparing method |
| 08/09/2006 | CN1814297A Acyclovir solubilization method in injection liquid |
| 08/09/2006 | CN1814296A Cataplasm substrate and its preparing method |
| 08/09/2006 | CN1814295A Method for preparing gene therapeutic tissue engineering stent |
| 08/09/2006 | CN1814294A Corn SOD liposome and its preparing method |
| 08/09/2006 | CN1814293A Method for preparing PH-responding medicine release system by virus coating |
| 08/09/2006 | CN1814280A Regenerated human blood-platelet derivative growth factor gel |
| 08/09/2006 | CN1814275A Nano compound eye-drop containing piptide-like medicine and preparing method |
| 08/09/2006 | CN1813937A Compound formulation for treating hyperlipidemia and its preparing method |
| 08/09/2006 | CN1813880A Radix gentianae total aglycone dropping pill and its preparing method |
| 08/09/2006 | CN1813772A Biomedicinal gel formulation for treating alveolysis and its preparing method |
| 08/09/2006 | CN1813763A Lycopene/beta-cyclodextrin supermolecular composition and its preparation |
| 08/09/2006 | CN1813720A Epothilone slow-release implanting composition and use |
| 08/09/2006 | CN1813699A Medicinal composition |
| 08/09/2006 | CN1813691A Decanoyl acetaldehyde compound and its medicinal composition |
| 08/09/2006 | CN1813688A Wound bandage and plaster |
| 08/09/2006 | CN1813687A Method for preparing tinidazole biological composite membrane |
| 08/09/2006 | CN1813684A Method for preparing 5-fluorouracil/chitosan nano drug-carrying microsphere |
| 08/09/2006 | CN1813682A Method for preparing fat-soluble medicine nano micro particle |
| 08/09/2006 | CN1813677A Quercetin long-acting liposome powder for injection and its preparing method |
| 08/09/2006 | CN1813675A Galanthamine hydrobromide composition and its preparing method |
| 08/09/2006 | CN1813559A Composition for regulating animal growth, method of manufacture and use thereof |
| 08/09/2006 | CN1268743C genetic construct for coding cell targeting part and heterologous precursor activating enzyme, and its application |
| 08/09/2006 | CN1268741C Therapy for 'alpha'-galactosidase deficiency |
| 08/09/2006 | CN1268668C Polypeptide grafted copolymer for preparation of nano drug-carrying micell |
| 08/09/2006 | CN1268641C 载脂蛋白类似物 Apolipoprotein analogues |
| 08/09/2006 | CN1268624C A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidine-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl) benzo[b] thiophene hydrochloride |
| 08/09/2006 | CN1268623C Novel composition and method or stabilizing same |
| 08/09/2006 | CN1268396C Compositions of estrogen-cyclodextrin complexes |
| 08/09/2006 | CN1268340C Pharmaceutical composition comprising condensed indole compound |
| 08/09/2006 | CN1268336C Pharmaceutical composition, dosage form, and method of epothilones for oral administration |
| 08/09/2006 | CN1268334C Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
| 08/09/2006 | CN1268326C Novel formulations of alpha 2,4-disulforphenyl-N-tert-butylnitrone |
| 08/09/2006 | CN1268321C Lyophilizing composition of drug-encapsulating polymer micelle and method for preparation thereof |
| 08/09/2006 | CN1268320C Synergistic filler composition |
| 08/08/2006 | US7089053 using menthol and 5 to 30% polyhydric alcohol for increased percutaneous absorption |
| 08/08/2006 | US7087723 Stable in the absence of albumin or other proteins |
| 08/08/2006 | US7087709 Nitrosation of a organosulfur polymer; coating medical equipment such as tubes, catheters |
| 08/08/2006 | US7087647 Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
| 08/08/2006 | US7087642 Inhibitors of IMPDH enzyme |
| 08/08/2006 | US7087600 Anticancer agents; side effect reduction |
| 08/08/2006 | US7087588 to gastrointestal systems, kidneys |
| 08/08/2006 | US7087587 Blending with adjuvants, compression, coating |
| 08/08/2006 | US7087585 Tripeptide of FcγRIIA |
| 08/08/2006 | US7087578 Administering activated protein c; controlling blood coagulation |
| 08/08/2006 | US7087577 Method of promoting natural bypass |
| 08/08/2006 | US7087263 Polymer coating for drug elution stent; cardiovascular disorders |
| 08/08/2006 | US7087249 Nanocrystalline antimicrobial metals (noble metals)formed with atomic disorder are capable of releasing highly active clusters of the antimicrobial metal sufficient to cause microbiocidal effect; anti-inflammatory activity |
| 08/08/2006 | US7087248 Pharmaceutical component based on human parathyroid hormone and a pharmaceutical composition for intranasal administration comprising the component |
| 08/08/2006 | US7087247 Polyesters, method for producing same, and depot medicaments produced from these polyesters |
| 08/08/2006 | US7087246 Controlled release preparation of insulin contains microparticles obtained by microencapsulation of uniform microcystals of insulin using biodegradable polymeric materials. Since the denaturation of insulin that may occur |
| 08/08/2006 | US7087244 Thermogelling oligopeptide polymers |
| 08/08/2006 | US7087241 Administering a transmucosal formulation, comprising oxybutynin to a subject to provide a plasma area under the curve (AUC) ratio of oxybutynin to an oxybutynin metabolite of from about 0.5:1 to about 5:1, wherein the transmucosal formulation optionally includes a permeation enhancer |
| 08/08/2006 | US7087229 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 08/08/2006 | US7087224 Method of treating anemia by administering IL-1ra |
| 08/08/2006 | US7087217 Condensation aerosol for delivery of a drug selected from the group consisting of indomethacin, ketoprofen, celcoxib, rofecoxib, meclofenamic acid, fenoprofen, diflunisal, tolfenamic acid, naproxen, ibuprofen, flurbiprofen and nabumetone |
| 08/08/2006 | US7087216 Condensation aerosol for delivery of a drug selected from the group consisting of zaleplon, zolpidem and zopiclone |
| 08/08/2006 | US7087215 Methods of administering and enhancing absorption of pharmaceutical agents |
| 08/08/2006 | US7087212 Multilayer binding; lamellar surface structure |
| 08/08/2006 | CA2431368C Intraocular irrigating solution having improved flow characteristics |
| 08/08/2006 | CA2394902C Effervescent histamine h2 antagonist composition |
| 08/08/2006 | CA2348016C Controlled release liquid delivery compositions with low initial drug burst |
| 08/08/2006 | CA2274959C Individually dosed foil-form presentation which decomposes rapidly on contact with liquid and contains an active substance, in particular an aromatic substance |
| 08/08/2006 | CA2193503C Butylene oxide-ethylene oxide block copolymer surfactants as stabilizer coatings for nanocrystal formulation |
| 08/08/2006 | CA2188464C Collagen preparation for the controlled release of active substances |
| 08/08/2006 | CA2110899C Orally administrable therapeutic proteins and method of making |
| 08/03/2006 | WO2006081279A2 Control of drug release by transient modification of local microenvironments |
| 08/03/2006 | WO2006081147A1 Methods of treating various conditions by administration of sustained release l-arginine |
| 08/03/2006 | WO2006080778A1 Solid dispersion comprising tacrolimus and enteric-coated macromolecule |
| 08/03/2006 | WO2006080508A1 Transdermal absorption preparation, sheet holding transdermal absorption preparation and transdermal absorption preparation holder |
| 08/03/2006 | WO2006080498A1 Tablets containing ornithine hydrochloride |
| 08/03/2006 | WO2006080481A1 Multiple unit oral sustained release preparation and process for production of the same |
| 08/03/2006 | WO2006080452A1 Method for producing fine particle surface-modified with water-soluble substance |
| 08/03/2006 | WO2006080451A1 Process for producing coated fine particle |
| 08/03/2006 | WO2006080398A1 Composition for preparing carbon dioxide preparation for external use |
| 08/03/2006 | WO2006080328A1 Esterified catechin, process for producing the same, food and drink or cosmetic containing the same |
| 08/03/2006 | WO2006080312A1 Method for producing adsorptive porous body |
| 08/03/2006 | WO2006080199A1 Patch |
| 08/03/2006 | WO2006080157A1 Molecular aggregate capable of undergoing phase transition by dehydrating condensation and method of phase transition thereof |
| 08/03/2006 | WO2006080118A1 Composition for inhibiting expression of target gene |
| 08/03/2006 | WO2006079830A1 Alkoxylated lanolin derivatives and compositions therewith |
| 08/03/2006 | WO2006079815A1 Stabilised plant extract and its therapeutic use |
| 08/03/2006 | WO2006079722A2 Compositions for freeze-drying proteins |
| 08/03/2006 | WO2006079641A2 Insulin derivatives conjugated with structurally well defined branched polymers |
| 08/03/2006 | WO2006079216A1 Liposomal compositions for parenteral delivery of agents |
| 08/03/2006 | WO2006079209A1 Pulmonary compositions comprising a vitamin a compound and a surfactant and uses thereof |
| 08/03/2006 | WO2006056227A8 Conjugates comprising the active agent and flanking or branched-chain peptides |
| 08/03/2006 | WO2006052363A3 Co-expression of multiple protein chains or subunits |
| 08/03/2006 | WO2006042574A3 Sodium ascorbate solubilisate |
| 08/03/2006 | WO2006019950A3 Conjugates of a gm-csf moiety and a polymer |